Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.

Humans Catheter-Related Infections / epidemiology Catheterization, Central Venous / adverse effects Central Venous Catheters / adverse effects Neoplasms / complications Sepsis / etiology Subclavian Vein Male Female
Bloodstream infection CRBSI Central venous catheter-related infection Femoral CVC Jugular vein CVC Subclavian vein CVC

Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 22 01 2023
accepted: 23 03 2023
medline: 19 7 2023
pubmed: 5 4 2023
entrez: 4 4 2023
Statut: ppublish

Résumé

Overall, insertion of central venous catheter (CVC) into femoral veins (FV) has been shown to be associated with a higher risk of infection compared with subclavian and internal jugular (IJV/SCV) CVC, but no data are available on the impact of the FV insertion site on the CVC-related bloodstream infections (CRBSI) risk in patients with cancer. The objective of the study is to compare CRBSI rates and incidences of FV with those of internal jugular and subclavian vein (IJV/SCV CVC) as observed in the prospective SECRECY registry. SECRECY is an ongoing observational, prospective, clinical CRBSI registry active in six departments of hematology/oncology in Germany. Each case of FV CVC was matched at a ratio of 1:1 to a case with IJV/SCV CVC. The propensity score was estimated using a multivariable logistic regression model adjusting for age, sex, cancer type, and duration of indwelling catheter. Of 4268 CVCs included in this analysis, 52 (1.2%) were inserted into the FV and 4216 (98.8%) into the IJV/SCV. 52 cases of FV CVC were matched with 52 IJV/SCV CVC. There was no significant difference in the CRBSI rate (3.8% vs. 9.6%), the CRBSI incidence (5.7 vs. 14.2/1000 CVC days), and the median CVC time (5.5 vs. 5 days) between the FV and the IJV/SCV group. Based on this data, inserting FV CVCs in patients with cancer does, at least in the short-term, not appear to be associated with an increased risk of CRBSI as compared to IJV/SCV CVC.

Identifiants

DOI: 10.1007/s15010-023-02029-4 PMID: 37016194
pubmed: 37016194
doi: 10.1007/s15010-023-02029-4
pii: 10.1007/s15010-023-02029-4
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1153-1159

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Böll B, Schalk E, Buchheidt D, et al. Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2021;100:239–59.
doi: 10.1007/s00277-020-04286-x pubmed: 32997191
O’Grady NP, Alexander M, Burns LA, et al. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52:e162-93.
doi: 10.1093/cid/cir257 pubmed: 21460264 pmcid: 3106269
Parienti JJ, Mongardon N, Mégarbane B, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373:1220–9.
doi: 10.1056/NEJMoa1500964 pubmed: 26398070
Arvaniti K, Lathyris D, Blot S, et al. Cumulative evidence of randomized controlled and observational studies on catheter related infection risk of central venous catheter insertion site in ICU patients: a pairwise and network meta-analysis. Crit Care Med. 2017;45:e437–48.
doi: 10.1097/CCM.0000000000002092 pubmed: 27632678
Parienti JJ. Catheter-related bloodstream infection in jugular versus subclavian central catheterization. Crit Care Med. 2017;45:e734–5.
doi: 10.1097/CCM.0000000000002400 pubmed: 28622231
Rixecker T, Lesan V, Ahlgrimm M, et al. Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy. Bone Marrow Transplant. 2021;56:195–201.
doi: 10.1038/s41409-020-01003-0 pubmed: 32704092
Heidenreich D, Hansen E, Kreil S, et al. The insertion site is the main risk factor for central venous catheter-related complications in patients with hematologic malignancies. Am J Hematol. 2022;97:303–10.
doi: 10.1002/ajh.26445 pubmed: 34978721
Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Prävention von Infektionen, die von Gefäßkathetern ausgehen Teil 1 – Nichtgetunnelte zentralvenöse Katheter. Bundesgesundheitsbl. 2017;60:171–206.
doi: 10.1007/s00103-016-2487-4
Hentrich M, Schalk E, Schmidt-Hieber M, et al. Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology. Ann Oncol. 2014;25:936–47.
doi: 10.1093/annonc/mdt545 pubmed: 24399078
Schalk E, Tölle D, Schulz S, et al. Identifying haematological cancer patients with high risk for central venous catheter (CVC)-related bloodstream infections at the time point of CVC insertion. 29th European Congress of Clinical Microbiology and Infectious Diseases, April 13–16, 2019, Amsterdam, The Netherlands, abstract P2556. https://www.escmid.org/escmid_publications/escmid_elibrary . Published 2019. Accessed 30 May 2022.
Ho DE, Imai K, King G, Stuart EA. MatchIt: Nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1–28. https://doi.org/10.18637/jss.v042.i08 .
doi: 10.18637/jss.v042.i08
Timsit JF, Bouadma L, Mimoz O, et al. Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials. Am J Respir Crit Care Med. 2013;188:1232–9.
doi: 10.1164/rccm.201303-0460OC pubmed: 24127770
Heidenreich D, Hansen E, Kreil S, et al. Influence of the insertion site on central venous catheter-related complications in patients undergoing allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2020;26:1189–94.
doi: 10.1016/j.bbmt.2020.02.007 pubmed: 32084541
Snarski E, Stringer J, Mikulska M, et al. Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT. Bone Marrow Transplant. 2021;56:2929–33.
doi: 10.1038/s41409-021-01430-7 pubmed: 34420041

Auteurs

Marcus Hentrich (M)

Department of Hematology and Oncology, Red Cross Hospital Munich, University of Munich, Nymphenburger Str. 163, 80634, Munich, Germany. marcus.hentrich@swmbrk.de.

Boris Böll (B)

Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD), Aachen, Germany.

Daniel Teschner (D)

Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the, Johannes Gutenberg University Mainz, Mainz, Germany.

Jens Panse (J)

Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD), Aachen, Germany.
Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Timo Schmitt (T)

Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the, Johannes Gutenberg University Mainz, Mainz, Germany.
Hamm Hospital Nahetal, Bad Kreuznach, Germany.

Jan-Hendrik Naendrup (JH)

Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD), Aachen, Germany.

Martin Schmidt-Hieber (M)

Clinic of Hematology, Oncology, Pneumology and Nephrology, Carl-Thiem Hospital Cottbus, Cottbus, Germany.

Julia Neitz (J)

Department of Hematology and Oncology, Red Cross Hospital Munich, University of Munich, Nymphenburger Str. 163, 80634, Munich, Germany.

Eva Fiegle (E)

Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD), Aachen, Germany.
Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Enrico Schalk (E)

Department of Hematology and Oncology, Medical Center, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Impact of the insertion site of central venous...
questionsmedicales.fr › Infection › Infections sur cathéters › Impact of the insertion site of central venous...
questionsmedicales.fr › Techniques d'investigation › Cathétérisme › Cathétérisme veineux central › Impact of the insertion site of central venous...
questionsmedicales.fr › Équipement et fournitures › Cathéters › Dispositifs d'accès vasculaires › Voies veineuses centrales › Impact of the insertion site of central venous...
questionsmedicales.fr › Tumeurs › Impact of the insertion site of central venous...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Sepsie › Impact of the insertion site of central venous...
questionsmedicales.fr › Système cardiovasculaire › Vaisseaux sanguins › Veines › Veine subclavière › Impact of the insertion site of central venous...